Business

Aurobindo Pharma to spend $200 million on Capex in FY20

Aurobindo Pharma to spend $200 million on Capex in FY20 The acquisition will add approximately 300 products, including projects under development, as well as commercial and manufacturing capabilities in the USA.

from Moneycontrol Business News
Read The Rest:moneycontrol...

Realted Posts